UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000006951
Receipt number R000008209
Scientific Title The investigation for the period of proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection
Date of disclosure of the study information 2011/12/26
Last modified on 2013/12/26 09:51:28

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The investigation for the period of proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection

Acronym

The investigation for the period of PPI for gastric ulcer after ESD

Scientific Title

The investigation for the period of proton pump inhibitor for gastric ulcer after endoscopic submucosal dissection

Scientific Title:Acronym

The investigation for the period of PPI for gastric ulcer after ESD

Region

Japan


Condition

Condition

patients with gastric cancer or adenoma who underwent ESD

Classification by specialty

Gastroenterology Adult

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

Efficacy of 2 weeks of PPI administration compared to 4 weeks on reduction in area of gastric ulcer after ESD

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Reduction rate in area of gastric ulcer after ESD

Key secondary outcomes

QOL (GSRS) at 4 weeks after ESD
Relation between GSRS and reduction rate.


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Dose comparison

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

esomeprazole 20mg per day for 4 weeks

Interventions/Control_2

esomeprazole 20mg per day for 2 weeks

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with gastric cancer or adenoma who underwent ESD

Key exclusion criteria

(1) patients with gastrectomy during treatment
(2) patients who are pregnant or nursing
(3) patients with severe liver or renal dysfunction
(4) patients with use of anti-thrombosis drug
(5) patients wit bleeding tendency
(6) drug allergy for esomeprazole
(7) patients who are diagnosed as unsuitable for this trial by investigator

Target sample size

30


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Makoto Arai

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba City

TEL

043-226-2083

Email

araim-cib@umin.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Makoto Arai

Organization

Chiba University Hospital

Division name

Gastroenterology

Zip code


Address

1-8-1 Inohana, Chuo-ku, Chiba City, JAPAN

TEL

043-226-2083

Homepage URL


Email

araim-cib@umin.ac.jp


Sponsor or person

Institute

Chiba University Hospital

Institute

Department

Personal name



Funding Source

Organization

Chiba University

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

千葉大学病院


Other administrative information

Date of disclosure of the study information

2011 Year 12 Month 26 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 12 Month 26 Day

Date of IRB


Anticipated trial start date

2012 Year 01 Month 01 Day

Last follow-up date

2013 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 12 Month 26 Day

Last modified on

2013 Year 12 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008209


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name